Ms Debbie Milan Esque, LPC | |
105 Blair Dr, Archdale, NC 27263-3378 | |
(336) 471-8628 | |
Not Available |
Full Name | Ms Debbie Milan Esque |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 105 Blair Dr, Archdale, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164568408 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | 3812 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Debbie Milan Esque, LPC 105 Blair Dr, Archdale, NC 27263-3378 Ph: (336) 471-8628 | Ms Debbie Milan Esque, LPC 105 Blair Dr, Archdale, NC 27263-3378 Ph: (336) 471-8628 |
News Archive
Despite increasing awareness of how critical sleep is to our health, getting a good night's rest remains increasingly difficult in a world that's always "on" -; responding to emails at all hours, news cycles that change with every tweet and staring endlessly into the blue light of cell phone, tablet and computers screens.
Aging-US published "The role of age at menarche and age at menopause in Alzheimer's disease: evidence from a bidirectional mendelian randomization study" which reported that the association between endogenous estrogen exposure and Alzheimer's disease remains inconclusive in previous observational studies, and few Mendelian randomization studies have focused on their causality thus far.
Patients who receive hemodialysis are at a significant risk of developing infections, a leading cause of hospitalization and death in this patient population.
Genetic Analysis AS, the molecular diagnostics company, has launched its GA-map™ microarray test for high throughput screening of infant gut microbiota. At the recent Sackler Colloquium on Microbes and Health in the US, the company presented data from evaluation screens that show its potential as a tool for probing the mechanisms of disease in conditions associated with the gut flora.
Oncolytics Biotech Inc. today announced that it has met the primary overall statistical endpoint in its U.S. Phase 2 single arm clinical trial in patients with squamous cell carcinoma of the lung using intravenous administration of REOLYSIN in combination with carboplatin and paclitaxel in patients with metastatic stage IIIB, or stage IV, or recurrent SCCLC who are chemotherapy naïve for their metastatic or recurrent cancer (REO 021).
› Verified 1 days ago
Courtney Tuckfield Gill, M.A., LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 205 Balfour Dr, Archdale, NC 27263 Phone: 336-431-0700 Fax: 336-431-0762 | |
Aleasha Mitchell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 6465 Allendale Dr, Archdale, NC 27263 Phone: 409-504-5799 | |
Ashley Fowler Ginoba, LCSW, LICSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 205 Balfour Dr, Archdale, NC 27263 Phone: 336-431-0700 | |
Darryl Jones, Counselor Medicare: Not Enrolled in Medicare Practice Location: 6136 Ashbrook Circle, Archdale, NC 27263 Phone: 336-633-9820 | |
Brenda S Blackwell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 205 Balfour Dr, Archdale, NC 27263 Phone: 800-422-8034 | |
Steven Justin Boul, NCC, LPC(BE) Counselor Medicare: Not Enrolled in Medicare Practice Location: 205 Balfour Dr, Archdale, NC 27263 Phone: 336-431-0700 Fax: 336-431-0762 |